Edwards Lifesciences Corp. (EW) News

Edwards Lifesciences Corp. (EW): $69.97

0.19 (+0.27%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

B

Filter EW News Items

EW News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

EW News Highlights

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

Latest EW News From Around the Web

Below are the latest news stories about EDWARDS LIFESCIENCES CORP that investors may wish to consider to help them evaluate EW as an investment opportunity.

Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

IRVINE, Calif., January 07, 2025--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, 2025.

Yahoo | January 7, 2025

Edwards Lifesciences Corporation (NYSE:EW) is largely controlled by institutional shareholders who own 85% of the company

Key Insights Institutions' substantial holdings in Edwards Lifesciences implies that they have significant influence...

Yahoo | January 6, 2025

Edwards Lifesciences price target raised to $75 from $69 at Evercore ISI

Evercore ISI raised the firm’s price target on Edwards Lifesciences (EW) to $75 from $69 and keeps an In Line rating on the shares. In the firm’s 2025 outlook note for MedTech, Life Science Tools and Diagnostics, the analyst argues that FY25 guides from the life science tools group are likely to be conservative on China and Pharma, while in MedTech the firm contends that “healthy” utilization trends and a margin expansion thesis support the group. Published first on TheFly – the ultimate source

Yahoo | January 3, 2025

Top 10 medtech deals of 2024

Multibillion-dollar buyouts returned last year, led by Johnson & Johnson’s $13.1 billion acquisition of Shockwave Medical.

Yahoo | January 2, 2025

Edwards Lifesciences Corporation (EW): Among the Cheap Healthcare Stocks to Buy Heading Into 2025

We recently compiled a list of the 12 Cheap Healthcare Stocks to Buy Heading into 2025. In this article, we are going to take a look at where Edwards Lifesciences Corporation (NYSE:EW) stands against the other cheap healthcare stocks. The Resilience and Challenges of Global Healthcare Spending Investing in healthcare equities is typically seen as protective […]

Yahoo | December 28, 2024

A Look At The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Edwards Lifesciences fair value estimate is US$64.46 Current...

Yahoo | December 26, 2024

DexCom (DXCM) Soars 5.6%: Is Further Upside Left in the Stock?

DexCom (DXCM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Yahoo | December 23, 2024

Jim Cramer: Is Edwards Lifesciences (EW) Poised for a Comeback?

We recently compiled a list of the 7 Stocks that Jim Cramer Recently Discussed. In this article, we are going to take a look at where Edwards Lifesciences Corporation (NYSE:EW) stands against the other stocks that Jim Cramer has recently discussed. Jim Cramer, host of Mad Money, recently addressed how investors can sometimes lose sight […]

Yahoo | December 20, 2024

Is the Options Market Predicting a Spike in Edwards (EW) Stock?

Investors need to pay close attention to Edwards (EW) stock based on the movements in the options market lately.

Yahoo | December 20, 2024

CMS proposes Medicare coverage for transcatheter tricuspid replacement

Edwards submitted a request for a national coverage determination in February, after receiving FDA approval for its Evoque device earlier that month.

Yahoo | December 20, 2024


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!